GGrantIndex
← Leaderboards

Laura P James

University Of Arkansas Med Scis Ltl Rock

$49,128,373
Attributed
$55,733,713
Total exposure
16
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.4M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$55,733,713 · 16

By mechanism

UL1$27,851,310 · 2
UM1$7,916,776 · 1
U54$3,497,558 · 1
SB1$3,458,961 · 1
OT2$3,333,725 · 1
R01$3,203,148 · 2

Top collaborators

Most similar at University Of Arkansas Med Scis Ltl Rock

Same institution · by research overlap

Others in their field

Top investigators on “Future

Research focus

FutureProgramsResearch PersonnelAcetaminophenBaseArkansasMedicalLeadClinical ResearchDoseUnited StatesInnovationScienceUniversitiesAdductToxic EffectCollaborationsFoundationsPharmaceutical PreparationsTrainingLiverBinding (Molecular Function)HepatotoxicityOverdose

Grant awards (54)

Expanding Translational Science in Arkansas$3,824,629
UM1 · FY2025 · TR · contact PI
Primary Care HEART-NET in the Deep South$1,999,477
OT2 · FY2025 · OD
Primary Care HEART-NET in the Deep South$1,334,248
OT2 · FY2025 · OD
AcetaSTAT Validation and Commercialization$1,067,121
SB1 · FY2025 · DK · contact PI
Expanding Translational Science in Arkansas$214,200
UM1 · FY2025 · TR · contact PI
Expanding Translational Science in Arkansas$3,877,947
UM1 · FY2024 · TR · contact PI
Expanding Translational Research in Arkansas$4,269,045
UL1 · FY2023 · TR · contact PI
AcetaSTAT Validation and Commercialization$1,068,321
SB1 · FY2023 · DK · contact PI
100 Additional fresh samples for verification of assay to replace the original proposed banked samples that cannot be used due to repeated exposure to freezing and thawing.$253,798
SB1 · FY2023 · DK · contact PI
Expanding Translational Research in Arkansas$4,269,045
UL1 · FY2022 · TR · contact PI
AcetaSTAT Validation and Commercialization$1,069,721
SB1 · FY2022 · DK · contact PI
Expanding Translational Research in Arkansas$4,378,981
UL1 · FY2021 · TR · contact PI
Expanding Translational Research in Arkansas$4,112,181
UL1 · FY2020 · TR · contact PI
Arkansas ECHO ISPCTN Site (AREIS)$420,750
UG1 · FY2020 · OD · contact PI
CTSA Admin Supp2 Maternal Mortality - UL1 - Revision$228,000
UL1 · FY2020 · TR · contact PI
CTSA Admin Supp QAQC - UL1 - Revision$156,864
UL1 · FY2020 · TR · contact PI
CTSA supplement$111,152
UL1 · FY2020 · TR · contact PI
Expanding Translational Research in Arkansas$4,113,146
UL1 · FY2019 · TR · contact PI
Expanding Translational Research in Arkansas$3,497,558
U54 · FY2017 · TR · contact PI
Arkansas Center for Advancing Pediatric Therapeutics (ArCAPT)$1,786,542
UG1 · FY2016 · OD · contact PI
Arkansas Center for Advancing Pediatric Therapeutics (ArCAPT)$69,094
UG1 · FY2016 · HD
Arkansas Center for Clinical and Translational Research$2,640,290
UL1 · FY2014 · TR · contact PI
Arkansas Center for Clinical and Translational Research$107,877
UL1 · FY2014 · TR · contact PI
Arkansas Center for Clinical Translational Research$80,483
KL2 · FY2014 · TR · contact PI
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity$59,356
R42 · FY2014 · DK · contact PI
Arkansas Center for Clinical and Translational Research$3,464,729
UL1 · FY2013 · TR · contact PI
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity$568,564
R42 · FY2013 · DK · contact PI
Identification of new mechanistic biomarkers of adverse responses to acetaminophe$326,072
R01 · FY2013 · DK · contact PI
Arkansas Center for Clinical Translational Research$195,949
KL2 · FY2013 · TR · contact PI
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity$698,788
R42 · FY2012 · DK · contact PI
Biomarkers of adverse responses to acetaminophen in children and adolescents$374,079
R01 · FY2012 · DK · contact PI
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity$389,762
R42 · FY2011 · DK · contact PI
Identification of new mechanistic biomarkers of adverse responses to acetaminophe$374,079
R01 · FY2011 · DK · contact PI
HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair$247,088
R01 · FY2011 · DK · contact PI
Identification of new mechanistic biomarkers of adverse responses to acetaminophe$400,521
R01 · FY2010 · DK · contact PI
HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair$249,584
R01 · FY2010 · DK · contact PI
Dipstick Assay for Detection of Acetaminophen Protein Adducts$89,043
R41 · FY2010 · DK · contact PI
Identification of new mechanistic biomarkers of adverse responses to acetaminophe$474,962
R01 · FY2009 · DK · contact PI
HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair$252,105
R01 · FY2009 · DK · contact PI
Pediatric Pharmacology Research Unit Network$207,139
U10 · FY2009 · HD · contact PI
Dipstick Assay for Detection of Acetaminophen Protein Adducts$199,795
R41 · FY2009 · DK · contact PI
HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair$1,470
R01 · FY2009 · DK · contact PI
Pediatric Pharmacology Research Unit Network$369,177
U10 · FY2008 · HD · contact PI
HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair$214,157
R01 · FY2008 · DK · contact PI
Dipstick Assay for Detection of Acetaminophen Protein Adducts$199,751
R41 · FY2008 · DK · contact PI
HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair$37,031
R01 · FY2008 · DK · contact PI
Pediatric Pharmacology Research Unit Network$365,742
U10 · FY2007 · HD · contact PI
HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair$252,000
R01 · FY2007 · DK · contact PI
Evaluation of a Biomarker for Acetaminophen Toxicity$131,000
R03 · FY2005 · DK
Evaluation of a Biomarker for Acetaminophen Toxicity$131,000
R03 · FY2004 · DK
NOVEL THERAPIES FOR ACETAMINOPHEN TOXICITY$129,870
K08 · FY2004 · DK
NOVEL THERAPIES FOR ACETAMINOPHEN TOXICITY$129,330
K08 · FY2003 · DK
NOVEL THERAPIES FOR ACETAMINOPHEN TOXICITY$128,250
K08 · FY2002 · DK
NOVEL THERAPIES FOR ACETAMINOPHEN TOXICITY$122,850
K08 · FY2001 · DK